INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Sun Pharmaceutical Industries Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524715	ISIN Demat INE044A01036	Book Value 98.33	NSE Symbol SUNPHARMA	Dividend Yield (%) 0.8	Market Cap (₹ Cr.) 404,899.77	P/E 128.53	EPS 13.13	Face Value 1

Particulars (₹ Cr)	Dec 2024	Sep 2024	Jun 2024	Mar 2024

Gross Sales/Income from operations	5985.33	5123.67	4409.74	5536.99
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	5,985.33	5,123.67	4,409.74	5,536.99
Other Operating Income	206.48	4.04	88.33	102.15
Total Income from operations (net)	6,191.81	5,127.71	4,498.07	5,639.14
Total Expenses	4,779.31	4,074.62	4,106.81	4,138.65
Cost of Sales	1,661.50	1,442.24	1,223.96	1,315.40
Employee Cost	651.68	662.19	645.48	575.97
Depreciation, amortization and depletion expense	290.97	285.53	369.81	393.04
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	2,175.16	1,684.66	1,867.56	1,854.24
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	1,412.50	1,053.09	391.26	1,500.49
Other Income	68.39	86.30	82.74	118.88
Profit from ordinary activities before finance costs and exceptional items	1,480.89	1,139.39	474.00	1,619.37
Finance Costs	215.96	243.75	216.08	217.59
Profit from ordinary activities after finance costs but before exceptional items	1,264.93	895.64	257.92	1,401.78
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	1,264.93	895.64	257.92	1,401.78
Total Tax	83.88	32.35	20.10	534.18
Net profit from Ordinary Activities After Tax	1,181.05	863.29	237.82	867.60
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	1,181.05	863.29	237.82	867.60
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	1,181.05	863.29	237.82	867.60
Other Comprehensive Income	-47.44	-19.40	16.58	-9.96
Total Comprehensive Income	1,133.61	843.89	254.40	857.64
Equity	239.93	239.93	239.93	239.93
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	4.90	3.60	1.00	3.60
EPS before Exceptional/Extraordinary items-Diluted	4.90	3.60	1.00	3.60
EPS after Exceptional/Extraordinary items-Basic	4.90	3.60	1.00	3.60
EPS after Exceptional/Extraordinary items-Diluted	4.90	3.60	1.00	3.60
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	10.50	0.00	0.00	0.00
Dividend (%)	1,050.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00